Palliative Nexus Research Group

Palliative Nexus | Professor Jennifer Philip

Ensuring equitable, best-practice palliative care for people with advanced cancer and their families.

Professor Jennifer Philip standing in front of white wall

While extraordinary advances are being made in cancer care, there are still around 45,000 Australians each year whose cancer cannot be cured. They deserve the same high level of attention and investment in care to maximise their quality of life as is directed towards the treatment of cancer itself.

Professor Jennifer Philip’s Palliative Nexus group is working to ensure people with advanced cancer receive the best, evidence-based end-of-life care.

The team brings together clinicians, researchers, and allied health professionals to effect positive and systemic change, accelerating the translation of research-generated knowledge into improved patient outcomes.

Achievements to date include developing benchmarks for access to palliative care, the incorporation of a triage tool into state and international settings, and the early adoption of palliative care models for people with cancer.

Much of the work of the Palliative Nexus Research Group is conducted through an equity lens, aiming to improve care for underserved groups including the growing prison population facing end of life in custody, people who are homeless, and through partnerships for First Nations peoples.

Palliative Nexus Research Group Research Pillars

The team has a series of research pillars each with a number of projects or programs of work. These pillars include: Health services research; Public health and community engagement research: Clinical trials; and Innovation to personalise care in advanced illness.

1. Service models in Serious Illness - ‘right care, right time, right place’

  • Informal caregivers disproportionately carry the burden of caring for patients with cancer, providing an estimated 75-90% of home-based care. Current economic evaluations of health services and interventions are based on the benefits to the formal healthcare system, while the financial impact on informal caregivers is routinely overlooked. To date, no standardised instrument exists to understand the economic impact of informal caregiving for cancer patients at the end-of-life.

    This mixed methods study aims to co-design a questionnaire that comprehensively captures the resources incurred by caregivers for cancer patients at the end-of-life, and to assess its feasibility, acceptability and face validity.  This work is overseen and co-designed with a community advisory group involving carers (current and bereaved), clinicians and health economists.

  • Worldwide, there is an increasing older prison population. People aged 50 or over make up 15% of the Australian prison population. This represents an increase of 84% in this age group between the years 2005 to 2015. The high incidence of multiple morbidity and the premature ageing within the prison setting mean that more and more people will face their end of life in custody. Prisons are designed and built with a younger, fit population in mind. The challenge of providing care to those people facing advanced cancer and other illnesses is very significant and escalating.

    We have adopted a mixed methods approach to understanding the barriers to best care and also exploring opportunities to improve care for people facing end of life while incarcerated. Working with our clinical partners, the outcomes of this research is now being formulated into interventions and approaches that are being translated into care.

  • The National Pancreatic Cancer Roadmap, developed by Cancer Australia, details a set of priorities towards improving care and outcomes for people affected by pancreatic cancer.  This project undertaken for Cancer Australia, led by Palliative Nexus in collaboration with investigator partners, aims to develop:

    • pathways to timely pain management and early palliative care,
    • Associated clinical guidance, education for health professionals, information for patients, &
    • digital and implementation recommendations to support the Roadmap.

    Working with experts and stakeholders from across the country, a longitudinal iterative co-production methodology informed by program logic and deliberative dialogue approaches will guide participant engagement, assess data from evidence reviews and participant experiences, and develop and achieve consensus on project outputs. Key stakeholders include clinicians (pain, palliative care, oncology, general practitioners, radiologists and gastroenterologists), patients, carers, community organisations, culturally and linguistically diverse, and Aboriginal and Torres Strait Islander peoples from all states and regions.

  • Based on background work focused upon improving outcomes for Aboriginal people with Advanced cancer and guided by a Cultural community Advisory group (comprised of First Nations cancer survivors, Aboriginal health workers, cancer professionals including Professors Gail Garvey and Jenny Phillip as well as representatives from WCMICS and VACCHO), a clear recommendation for establishing a First Nations Cancer Care Coordinator was made.

    Establishing and implementing this is project role was funded by the Western Central Melbourne Integrated Cancer Service (WCMICS).

    The role is being implemented at Royal Melbourne Hospital with patient and family focused care delivery as well as working with community organisations to facilitate optimal cultural support of people receiving cancer care across the illness course.

Family of four at the beach looking at ocean

The Care Plus Study

Care Plus is a multi-site study implementing palliative care for people with cancer to address the gaps between evidence and practice. It aims to reduce variation in clinical practice and ensure that best quality care is delivered in a timely and routine way.

The study takes a randomised, stepped-wedge approach, with ‘planning, engagement, intervention delivery, and evaluation’ stages at three cancer treatment centres. The goal is to improve health outcomes for patients with advanced cancer at a lower cost, with reduced hospitalisation rates.

Learn more

  • In 2024, Professor Jennifer Philip was awarded a Victorian Cancer Agency grant to lead a study offering early palliative care for people with high grade glioma. This further tests the  Care Plus model as it is  implemented for people with brain cancer using face-to-face and telehealth models to ensure access for all Victorians.

    The outcomes of this study will focus on the impact of the model of care itself upon quality of care, as well as the effectiveness of different implementation strategies across telehealth platforms and to regional patients.

  • Working with the VCCC and in collaboration with clinical partners (Royal Melbourne, Peter MacCallum and St Vincent’s Hospitals), the Care Plus model will be extended to involve delivery to people with lung, colorectal cancer or sarcoma. This will be undertaken in partnership with two regional centres – La Trobe and Albury-Wodonga Health.

    The outcomes of this study will also focus upon impact on health service use and the effective implementation strategies to bring about system level change.  Access and equity for achieving best care of regionally based people with cancer underpins this project.

Palliative care for underserved groups

Worldwide, there is an increasing older prison population. People aged 50 or over make up 15% of the Australian prison population. High incidence of multiple morbidity and premature ageing within the prison setting mean more and more people will face their end of life in custody. Prisons are designed and built with a younger, fit population in mind. The challenge of providing care to people facing advanced cancer and other illnesses is very significant and escalating.

The Palliative Nexus group have adopted a mixed methods approach to understanding the barriers to best care and also exploring opportunities to improve care for people facing end of life while incarcerated. Working with clinical partners, the outcomes of this research are being translated into care.

Read more

Man lying sick in hospital bed

2. Evolving Communities – ‘involving people, evolving care’

  • Voices for Palliative Care is a group of engaged consumers with lived experience in palliative care, committed to fostering meaningful collaboration and partnership in research activities, contribution to service planning and delivery, and community-driven advocacy. Ensuring palliative care is relevant to and addressing the needs of both patients and their carers is essential, and research which seeks to improve experiences of palliative care must be informed by, and undertaken in collaboration with those care recipients (and providers).

    Voices for Palliative Care offers a platform for community members  to collaborate and mentor each other and to partner with researchers, either collectively or individually, in order to enrich their studies and projects. Uniquely, the Voices members are actively involved in co-designing research which seeks to evaluate and measure the impact of their input into research initiatives.

  • While there is mature evidence to support early palliative care integration into cancer care, public views and misperceptions mean palliative care is often delayed if it is engaged with at all. Yet when people hear about the areas where palliative care assist, they are often open to referral.

    The Choice Project is testing different methods of providing information to the general public and to people with cancer, using videos, story telling and the presentation of evidence to understand what is the most accessible and effective way to hear about options for care when cancer doesn’t go away.

3. Clinical Trials - ‘expanding evidence base in palliative care’

  • The five-year Regional Victorian Trials Alliance, Linkages, Special populations, Equity (ReViTALISE) Program is a collaborative initiative offering critical, cancer-related clinical trials and research to regional Victoria.

    The Palliative Nexus group leads the Regional Palliative and Supportive Care Research stream of the program, providing palliative care patients at eight regional sites with access to clinical trials, including the use of registry and telehealth trials.

    The ReViTALISE Program was awarded $18.6 million from the Australian Government Medical Research Future Fund (MRFF) in October 2020. It hopes to address equity of access for a group of people who may have difficulty travelling, yet still wish to participate in trials of emerging research practices.

  • The COMET program, funded by the Cancer Council Victoria and the Victorian Cancer Agency aims to improve access to supportive & palliative care clinical trials for a group with unmet needs – community dwelling people with cancer. Currently this group of people are underrepresented in clinical trials.  The goal of this program is to use local solutions and telehealth platforms to facilitate participation by people living at home and cared for by community palliative care services.

    The COMET program supports and trains the community palliative care workforce in research and clinical trial methods, builds relationships between community and clinical trial services, builds systems to identify and steps to facilitate enrolment in clinical trials, and using digital platforms, develops clinical trials that are able to be conducted in the community environment.  In addition, a key outcome of this program is the building and consolidating networks of trialists and clinicians across local, regional and national centres.

  • The increasing availability of medicinal cannabis means collation of data regarding efficacy and toxicity of medicinal cannabis must occur in a post-marketing, real world setting.

    RAPID is a quality improvement program developed and auspiced by the University of Technology Sydney (PaCCSC, CST cooperative trial groups) which  prospectively documents the use of medications and non-pharmacological interventions commonly used in palliative and supportive care. It aims to capture ‘real-world’ data on the benefits or effects, as well as adverse effects of different interventions.

    Monitoring and documenting medicinal cannabis through the RAPID methodology is  enabling prospective monitoring of a medication to inform practices that are currently being undertaken without strong evidence.

4. Innovation in palliative care – ‘bringing new technologies to personalise care’

  • OPPtic is a pilot feasibility study establishing and interrogating a clinical opioid pharmacogenomics database in palliative care.

    Many people with cancer will require pain relief with opioids at some time in their illness. They are highly effective for most, but a group of people develop significant side effects. Currently, there is no means of predicting who will get these side effects.

    This study seeks to elucidate the clinical, biological and genetic factors that influence side effects and efficacy for the opioid drug class in a palliative care population of cancer patients. The goal is to personalise opioid prescriptions to improve pain relief.

  • People with advanced illness frequently experience significant symptoms which often fluctuate and may worsen. Many people are uncertain what to do if symptoms change, how to seek help, or who to contact, and many will wait until their next scheduled doctors appointment maybe leading to distress while waiting, or even the need for an emergency department visit.

    The PARTNER study has established a program of remote symptom monitoring system for people receiving palliative care thereby enabling them to alert their clinical teams of escalating symptoms using their smart phone. The pilot implementation study conducted at Royal Melbourne and Peter MacCallum Hospitals seeks to establish the feasibility and acceptability of the processes and systems, as well as document the impact upon patient care and experience.

Latest News

Loading...

Contact and more information

Professor Jennifer Philip
Melbourne Medical School 
jphilip@unimelb.edu.au
+61 3 9231 1267